Cargando…

Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders

Methylphenidate (MPH) reduces hyperactive-impulsive symptoms common in children with autism spectrum disorders (ASDs), however, response and tolerability varies widely. We hypothesized monoaminergic gene variants may moderate MPH effects in ASD, as in typically developing children with attention-def...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCracken, J T, Badashova, K K, Posey, D J, Aman, M G, Scahill, L, Tierney, E, Arnold, L E, Vitiello, B, Whelan, F, Chuang, S Z, Davies, M, Shah, B, McDougle, C J, Nurmi, E L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034115/ https://www.ncbi.nlm.nih.gov/pubmed/23856854 http://dx.doi.org/10.1038/tpj.2013.23

Ejemplares similares

Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
por: Nurmi, E L, et al.
Publicado: (2013)

Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2020)

Ensuring Safety of Operation Warp Speed Vaccines for COVID-19
por: McDougle, Leon
Publicado: (2020)

Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry
por: Payer, D E, et al.
Publicado: (2012)

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder
por: Wink, Logan K., et al.
Publicado: (2016)

Psychotherapy and medication management strategies for obsessive-compulsive disorder
por: Walsh, Kelda H, et al.
Publicado: (2011)

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan
por: Doyle, Carolyn A., et al.
Publicado: (2012)

The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)

CrossFit® open performance is affected by the nature of past competition experiences
por: Mangine, Gerald T., et al.
Publicado: (2022)

Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder
por: Schrantee, Anouk, et al.
Publicado: (2017)

Tourette's disorder and associated complex behaviors: a case report.
por: McDougle, C. J., et al.
Publicado: (1990)

Dissociable cognitive strategies for sensorimotor learning
por: McDougle, Samuel D., et al.
Publicado: (2019)

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
por: Olfson, Mark, et al.
Publicado: (2007)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Hyperactive behavioral phenotypes and an altered brain monoaminergic state in male offspring mice with perinatal hypothyroidism
por: Umezu, Toyoshi, et al.
Publicado: (2019)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Nair, Rajasree, et al.
Publicado: (2009)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
por: Rausch, Tessa L., et al.
Publicado: (2017)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
por: Arnett, Anne B., et al.
Publicado: (2022)

A rational pharmacologic approach toward a biologically meaningful subtype of autism spectrum disorder()()
por: Neumeyer, Ann M., et al.
Publicado: (2020)

Relationships Between Body Composition and Performance in the High-Intensity Functional Training Workout “Fran” are Modulated by Competition Class and Percentile Rank
por: Mangine, Gerald T., et al.
Publicado: (2022)

A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders
por: Minshawi, Noha F., et al.
Publicado: (2016)

Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study
por: Thom, Robyn P., et al.
Publicado: (2021)

Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)

Effectiveness of Using a Chief Complaint and Discharge Diagnosis Query in ESSENCE-FL to Identify Possible Tuberculosis Patients and Contacts in Hillsborough County, Florida
por: Wiese, Michael, et al.
Publicado: (2014)

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate
por: Buitelaar, J. K., et al.
Publicado: (2012)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
por: Shirafkan, Hoda, et al.
Publicado: (2020)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
por: Mandali, Alekhya, et al.
Publicado: (2021)

Pica in an Adolescent with Attention Deficit Hyperactivity Disorder responsive to Methylphenidate
por: Bourgou, Soumaya, et al.
Publicado: (2021)

Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trials
por: Müller, A. R., et al.
Publicado: (2021)

Monoaminergic Neuromodulation of Sensory Processing
por: Jacob, Simon N., et al.
Publicado: (2018)

Voices that may not otherwise be heard: a qualitative exploration into the perspectives of primary care patients living with chronic pain
por: Wallace, Lorraine S, et al.
Publicado: (2014)

Development and validation of the Patient Opioid Education Measure
por: Wallace, Lorraine S, et al.
Publicado: (2013)

Chemical and Physical Predictors of the Nutritive Value of Wheat in Broiler Diets
por: Ball, M. E. E., et al.
Publicado: (2013)

The Effect of Variety and Growing Conditions on the Chemical Composition and Nutritive Value of Wheat for Broilers
por: Ball, M. E. E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fuv7vatq2vv30oua8srrlsnj2f